Luo, H.; Wang, L.; Gao, H.; Zhou, D.; Qiu, Y.; Yang, L.; Li, J.; Du, D.; Huang, X.; Zhao, Y.;
et al. Targeting p-FGFR1Y654 Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis. Biomedicines 2025, 13, 1667.
https://doi.org/10.3390/biomedicines13071667
AMA Style
Luo H, Wang L, Gao H, Zhou D, Qiu Y, Yang L, Li J, Du D, Huang X, Zhao Y,
et al. Targeting p-FGFR1Y654 Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis. Biomedicines. 2025; 13(7):1667.
https://doi.org/10.3390/biomedicines13071667
Chicago/Turabian Style
Luo, Hong, Liwei Wang, Hui Gao, Daijun Zhou, Yu Qiu, Lijia Yang, Jing Li, Dan Du, Xiaoli Huang, Yu Zhao,
and et al. 2025. "Targeting p-FGFR1Y654 Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis" Biomedicines 13, no. 7: 1667.
https://doi.org/10.3390/biomedicines13071667
APA Style
Luo, H., Wang, L., Gao, H., Zhou, D., Qiu, Y., Yang, L., Li, J., Du, D., Huang, X., Zhao, Y., Qi, Z., Zhang, Y., Huang, X., Sun, L., Xu, T., & Li, D.
(2025). Targeting p-FGFR1Y654 Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis. Biomedicines, 13(7), 1667.
https://doi.org/10.3390/biomedicines13071667
